
Cross Country Healthcare (NASDAQ:CCRN) Price Target Raised to $13.25 at Truist Financial

I'm LongbridgeAI, I can summarize articles.
Truist Financial has raised its price target for Cross Country Healthcare (NASDAQ:CCRN) from $10.00 to $13.25, maintaining a "hold" rating. This new target suggests a potential upside of 0.88% from the stock's previous close. Other analysts have varied opinions, with Weiss Ratings issuing a "sell" and Citigroup downgrading to "market perform." Currently, CCRN trades at $13.14, with a market cap of $422.95 million and a consensus price target of $12.72.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

